Karyopharm Therapeutics Statistics
NASDAQ: KPTIHealth CareBiotechnology: Pharmaceutical PreparationsUSD
0.6074+0.0074 (+1.23%)
Market open · Delayed 15 min · as of Oct 9, 11:45 AM ET
Karyopharm Therapeutics by the numbers
Karyopharm Therapeutics has a market capitalization of $13.8 million based on 22.68M shares outstanding. With trailing EPS of $-14.33, Karyopharm Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 66.1% below its 50-day average and 90.8% below its 200-day average.
Average daily trading volume is 1.71M shares, or about $1.0 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
KPTI valuation vs. peer median
| Metric | KPTI | Peer median | Difference |
|---|---|---|---|
| Market cap | $13.78M | $13.64M | +1% |
| Avg. volume | 1.71M | 537.62K | +218% |
Peer median across 8 companies: TVRD, CTXR, CLRB, HIND, TPST, BFRI, AEON, BFRG.
Valuation
- Market cap
- $13.78M
- EPS (TTM)
- $-14.33
- Shares outstanding
- 22.68M
Price and trading
- Previous close
- 0.60
- Open
- 0.602
- Day range
- 0.582 – 0.6101
- 52-week range
- 0.582 – 10.99
- 52-week change
- -89.83%
- Beta
- —
- Volume
- 241.25K
- Average volume
- 1.71M
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 2, 2026
Additional statistics
- Market Cap
- 13.78M
- Forward Pe
- -0.22
- Eps
- -14.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 10.99
- Week52 Low
- 0.58
- Avg Volume
- 1.71M
- Shares Outstanding
- 22.68M
- Ma50
- 1.79
- Ma200
- 6.60
- Earnings Date
- Nov 2, 2026
- Pct From52w High
- -94.47%
- Pct From52w Low
- 4.36%